Protein phosphatase 2ACα gene knock-out results in cortical atrophy through activating hippo cascade in neuronal progenitor cells
Abstract
Protein phosphatase 2ACα (PP2ACα), a vital member of the protein phosphatase family, has been studied primarily as a regulator for the development, growth and protein synthesis of a lot of cell types. Dysfunction of PP2ACα protein results in neurodegenerative disease; however, this finding has not been directly confirmed in the mouse model with PP2ACα gene knock-out. Therefore, in this study presented here, we generated the PP2ACα gene knock-out mouse model by the Cre-loxP targeting gene system, with the purpose to directly observe the regulatory role of PP2ACα gene in the development of mouse's cerebral cortex. We observe that knocking-out PP2ACα gene in the central nervous system (CNS) results in cortical neuronal shrinkage, synaptic plasticity impairments, and learning/memory deficits. Further study reveals that PP2ACα gene knock-out initiates Hippo cascade in cortical neuroprogenitor cells (NPCs), which blocks YAP translocation into the nuclei of NPCs. Notably, p73, directly targeted by Hippo cascade, can bind to the promoter of glutaminase2 (GLS2) that plays a dominant role in the enzymatic regulation of glutamate/glutamine cycle. Finally, we find that PP2ACα gene knock-out inhibits the glutamine synthesis through up-regulating the activity of phosphorylated-p73 in cortical NPCs. Taken together, it concludes that PP2ACα critically supports cortical neuronal growth and cognitive function via regulating the signaling transduction of Hippo-p73 cascade. And PP2ACα indirectly modulates the glutamine synthesis of cortical NPCs through targeting p73 that plays a direct transcriptional regulatory role in the gene expression of GLS2.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Additional research in neuronal progenitor cells identified upregulation of Hippo signaling, witnessed by increased phosphorylation of MST1/2 (Ser180/183), LATS1 (Ser909) and YAP (Ser127), and inhibited nuclear translocation of YAP.
“Additional research in neuronal progenitor cells (NPCs) identified an upregulation of Hippo signaling, witnessed by an increased phosphorylation of MST1/2 (Ser180/183), LATS1 (Ser909) and YAP (Ser127), and inhibited nuclear translocation of YAP.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [47]
p53-like protein p73 phosphorylation (Tyr99) was enhanced, which could additionally contribute to the observed increase in apoptotic signaling and diminished proliferation of the Cα-/- neuronal progenitor cells.
“Furthermore, p53-like protein p73 phosphorylation (Tyr99) was enhanced, which could additionally contribute to the observed increase in apoptotic signaling and diminished proliferation of the Cα -/-NPCs [47].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [47]
Conditional loss of Ppp2ca in the nervous system resulted in severe microcephaly and cortical atrophy at P7, characterized by loss of cortical neurons and decreased thickness of cortical layers II-V.
“Conditional loss of Ppp2ca in the nervous system resulted in severe microcephaly and cortical atrophy at P7, characterized by loss of cortical neurons and decreased thickness of cortical layers II-V [47].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [47]
The animals performed poorly in a Morris water maze test, indicating learning and memory defects.
“The animals performed poorly in a Morris water maze test, indicating learning and memory defects.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [47]
Cites
1 retracted
Chen, C., Wei, X., Wang, S., Jiao, Q., Zhang, Y., Du, G., Wang, X., Wei, F., Zhang, J., & Lei, W. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.018 · Cited by 32 · see citing works
RetractedThe Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206 · see citing works
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,890 · see citing works
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886 · see citing works
Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,630 · see citing works
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/bj3530417 · Cited by 1,392 · see citing works
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231 · see citing works
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionPreprint
Zhao, B., Li, L., Lei, Q., & Guan, K. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,140 · see citing works
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zołnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793 · see citing works
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772 · cited 1× · see citing works
“According to the previous studies, the inhibition of PP2A gene expression has been proven to lead to the de-regulation of a lot of Ser/Thr kinases including GSK3β, ERK1/2 and JNK, which contributes to cytoskeleton abnormality, alteration of phosphorylated status of tau protein, generation of amyloidal precursor protei…”
BackgroundThe Ste20 group kinases as regulators of MAP kinase cascades
Dan, I., Watanabe, N. M., & Kusumi, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01980-8 · Cited by 629 · see citing works
Sontag, E., Nunbhakdi‐Craig, V., Lee, G. S., Bloom, G. S., & Mumby, M. C. (1996) · Neuron · doi:10.1016/s0896-6273(00)80250-0 · Cited by 391 · see citing works
PP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 366 · see citing works
Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules
Sontag, E., Nunbhakdi‐Craig, V., Lee, G. S., Brandt, R., Kamibayashi, C., Kuret, J., White, C. L., Mumby, M. C., & Bloom, G. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25490 · Cited by 305 · see citing works
Sontag, E., Nunbhakdi‐Craig, V., Bloom, G. S., & Mumby, M. C. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1131 · Cited by 301 · see citing works
Protein Kinases and Phosphatases in the Control of Cell Fate
Bononi, A., Agnoletto, C., Marchi, E. D., Marchi, S., Patergnani, S., Bonora, M., Giorgi, C., Missiroli, S., Poletti, F., Rimessi, A., et al. (2011) · Enzyme Research · doi:10.4061/2011/329098 · Cited by 283 · see citing works
Sontag, E., Nunbhakdi-Craig, V., Sontag, J.-M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S. R., Arning, E., & Bottiglieri, T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3316-06.2007 · Cited by 225 · see citing works
Planel, E., Yasutake, K., Fujita, S. C., & Ishiguro, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102780200 · Cited by 197 · see citing works
Strack, S., Zaucha, J. A., Ebner, F. F., Colbran, R. J., & Wadzinski, B. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980323)392:4 · Cited by 181 · see citing works
Sun, L., Liu, S. Y., Zhou, X. W., Wang, X. C., Liu, R., Wang, Q., & Wang, J. Z. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00697-8 · Cited by 168 · see citing works
Self-citationKins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155 · see citing works
LATS1 tumor suppressor regulates G2/M transition and apoptosis
Hong, X., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., & Tao, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205174 · Cited by 155 · see citing works
Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143 · see citing works
Excitatory Synaptic Transmission Persists Independently of the Glutamate–Glutamine Cycle
Kam, K., & Nicoll, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1198-07.2007 · Cited by 124 · see citing works
Yang, X., Li, D., Chen, W., & Xu, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204817 · Cited by 119 · see citing works
Louis, J. V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Longin, S., Zwaenepoel, K., Pijnenborg, R., Landrieu, I., Lippens, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018777108 · Cited by 112 · see citing works
S/P and T/P phosphorylation is critical for tau neurotoxicity in <i>Drosophila</i>
Steinhilb, M. L., Dias‐Santagata, D., Mulkearns, E. E., Shulman, J. M., Biernat, J., Mandelkow, E., & Feany, M. B. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21232 · Cited by 107 · see citing works
Wang, X., Blanchard, J., Kohlbrenner, E., Clement, N., Linden, R. M., Radu, A., Grundke, I., & Iqbal, K. (2010) · The FASEB Journal · doi:10.1096/fj.10-158477 · Cited by 81 · see citing works
McConnell, J. L., Gomez, R. J., McCorvey, L. R. A., Law, B. K., & Wadzinski, B. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210406 · Cited by 80 · see citing works
Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda‐Suzukake, M., Ishiguro, K., Plattner, F., Uchida, T., Isobe, T., Hasegawa, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433326 · Cited by 72 · see citing works
Xie, Y., Jüschke, C., Esk, C., Hirotsune, S., & Knoblich, J. A. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.027 · Cited by 72 · see citing works
Sontag, J., Nunbhakdi‐Craig, V., Mitterhuber, M., Ogris, E., & Sontag, E. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07049.x · Cited by 57 · see citing works
Zhao, Q., Zhao, M., Parris, A. B., Xing, Y., & Yang, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3588 · Cited by 56 · see citing works
Lyu, J., Kim, H.-R., Yamamoto, V. N., Choi, S. H., Wei, Z., Joo, C.-K., & Lu, W. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.034 · Cited by 48 · see citing works
c-Abl Tyrosine Kinase Selectively Regulates p73 Nuclear Matrix Association
Ben‐Yehoyada, M., Ben‐Dor, I., & Shaul, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301051200 · Cited by 47 · see citing works
Yao, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Liu, D., Chen, N., Ni, Z.-F., Wang, X., Wang, Q., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110347 · Cited by 47 · see citing works
Self-citationYao, X., Li, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Wang, Q., Wang, J., & Liu, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.018 · Cited by 37 · see citing works
Self-citationMedina, M., & Ávila, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.39 · Cited by 31 · see citing works
The p53 Family in Brain Disease
Agostini, M., Melino, G., & Bernassola, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7302 · Cited by 17 · see citing works
Huang, X., Liao, W., Huang, Y., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.096 · Cited by 16 · see citing works
Self-citationProtein phosphatase modulation of somatostatin receptor signaling in the mouse hippocampus
Lucas, S. J., & Armstrong, D. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.004 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Physiologic functions of PP2A: Lessons from genetically modified mice
Reynhout, S., & Janssens, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.010 · Cited by 124 · see citing works
Huang, C., Liu, T., Wang, Q., Hou, W., Zhou, C., Song, Z., Shi, Y. S., Gao, X., Chen, G., Yin, Z., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa042 · Cited by 14 · see citing works
Targeting PP2A in cancer: an underrated option
Sarais, F., Krempien, F., Koehn, C., Brewing, L., Classen, C. F., Walter, M., & Shokraie, O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03560-y · Cited by 8 · see citing works
- Authors
- Liu, B., Sun, L.-H., Huang, Y.-F., Guo, L.-J., & Luo, L.-S.
- Affiliations
- University of Maryland, Baltimore (US)
- Shandong University (CN)
- Jilin University (CN)
- Corresponding author
- Luo, Li-Shu
- ORCID
- Liu, Bo
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 95
- Pages
- 53-62
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W2776124176
- Cited by
- 29
- References
- 42
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The International Journal of Biochemistry & Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- protein phosphatase 2A, cortical atrophy, Hippo signaling pathway, YAP nuclear translocation, p73, GLS2, glutamine synthesis, glutamate-glutamine cycle, synaptic plasticity, learning and memory impairment, brain development
- MeSH terms
- Tumor Protein p73, Serine-Threonine Kinase 3, Hippo Kinases, Animals, Atrophy, Cells, Cultured, Crosses, Genetic, Embryo, Mammalian, Glutaminase, Hippocampus, Learning Disabilities, Memory Disorders, Mice, Transgenic, Nerve Tissue Proteins, Phosphorylation, Promoter Regions, Genetic, Protein Processing, Post-Translational, Signal Transduction, Protein Serine-Threonine Kinases, Genes, Reporter, Mice, Knockout, RNA Interference, Malformations of Cortical Development, Protein Phosphatase 2, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review